| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 37.639.650 $ | +4.041.675 $ | +26,3 % | 7 | 47.952.400 $ | +5.983.050 $ | +13,5 % | 8 | 48.698.189 $ | +6.175.410 $ | +21,8 % | 10 | ||||
| RIGEL PHARMACEUTICALS INC | RIGL | → 0 | Stark | 6.354.400 $ | -3.282.350 $ | -34,1 % | 1 | 9.636.750 $ | +3.262.500 $ | +51,2 % | 1 | 6.374.250 $ | +1.691.750 $ | +36,1 % | 1 |
| Trekor Metals Ltd | TGB | → 0 | Neutral | 9.622.000 $ | +1.796.500 $ | +23,0 % | 1 | 7.825.500 $ | +580.500 $ | +8,0 % | 1 | ||||
| ALICO, INC. | ALCO | → 0 | Neutral | 8.252.000 $ | +976.000 $ | +13,4 % | 1 | 7.276.000 $ | -175.900 $ | -2,4 % | 1 | 7.451.900 $ | +98.900 $ | +1,3 % | 1 |
| Royalty Pharma plc | RPRX | → 0 | Schwach | 5.996.250 $ | +3.098.250 $ | +106,9 % | 1 | ||||||||
| PREFORMED LINE PRODUCTS CO | PLPC | → 0 | Neutral | 5.167.750 $ | -324.450 $ | -5,9 % | 1 | 5.492.200 $ | +1.017.520 $ | +22,7 % | 1 | ||||
| AMICUS THERAPEUTICS, INC. | FOLD | → 0 | 5.268.800 $ | +1.722.800 $ | +48,6 % | 1 | 3.546.000 $ | +967.500 $ | +37,5 % | 1 | |||||
| RADIANT LOGISTICS, INC | RLGT | → 0 | Neutral | 4.582.500 $ | +468.000 $ | +11,4 % | 1 | 4.114.500 $ | -310.500 $ | -7,0 % | 1 | 4.425.000 $ | -135.000 $ | -3,0 % | 1 |
| INTEST CORP | INTT | → 0 | Neutral | 4.504.500 $ | +1.385.775 $ | +44,4 % | 1 | 3.284.839 $ | +222.915 $ | +7,3 % | 1 | ||||
| BGC Group, Inc. | BGC | → 0 | Stark | 4.401.000 $ | +829.000 $ | +23,2 % | 1 | 3.572.000 $ | +261.000 $ | +7,9 % | 1 | 3.311.000 $ | -269.500 $ | -7,5 % | 1 |
| Coherus Oncology, Inc. | CHRS | → 0 | Stark | 3.549.000 $ | +567.000 $ | +19,0 % | 1 | 3.444.000 $ | +1.798.575 $ | +109,3 % | 1 | ||||
| NEWMARK GROUP, INC. | NMRK | → 0 | Stark | 3.294.600 $ | -248.900 $ | -7,0 % | 1 | 3.543.500 $ | +202.250 $ | +6,1 % | 1 | ||||
| 37.639.650 $ | +4.041.675 $ | +26,3 % | 7 | 47.952.400 $ | +5.983.050 $ | +13,5 % | 8 | 48.698.189 $ | +6.175.410 $ | +21,8 % | 10 | ||||